Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR071658)
Received: 30 April 2019
Accepted: 9 October 2019
First Online: 4 November 2019
Ethics approval and consent to participate
: The TeMPO Trial has IRB approval from a sIRB at Partners HealthCare/Brigham and Women’s Hospital. Written informed consent is obtained from all study participants prior to randomization or any other study-ordered procedures take place.
: Not applicable.
: The authors declare that they have no competing interests.